Shorts

ePROs Help Reduce Hospitalizations and Improve Cancer Care

Why Real-World Data Is Critical to Understanding GLP-1s and Cancer Outcomes at ASCO 2026

APP-Led Scheduling Model Cuts Time to First Oncology Visit by Nearly 50%

SARC041 and the Future of Dedifferentiated Liposarcoma Treatment

Mary-Ellen Taplin, MD, and the Phase 3 PROTEUS Trial

Tackling Polypharmacy and Access Barriers After a Stroke

Pharmacists as a Constant in Stroke Recovery

Bridging the Gap After Hospital Discharge

Triptorelin: GnRH Agonist With Flexible Dosing for Prostate Cancer

Recurrent Strokes Are More Disabling

Why Patients Have Recurrent Strokes

Guselkumab: IL-23 Antagonist Across Four Inflammatory Conditions

Pharmacists' Vital Role in Stroke Care

Zenocutuzumab: First NRG1-Targeted Cancer Therapy

What Makes One Antimicrobial Strategy More Effective?

Naloxegol for Opioid-Induced Constipation

Vaccines Are the Best Way to Reduce Antibiotic Use

Four Questions That Can Improve Mental Health Decisions

Anagrelide: Platelet-Reducing Agent for Cancer-Related Thrombocytosis

Addressing the Unmet Need in Migraine Prevention

Wegovy HD: High-Dose Semaglutide for Greater Weight Loss

Pharmacy Technicians Serve as a Critical Safety Check in Clinical Practice

Sevabertinib: Kinase Inhibitor for Non-Small Cell Lung Cancer

Pneumococcal Disease Insights: Why Vaccination Matters

Doravirine/Islatravir: New Once-Daily HIV Combination

Understanding the Link Between Hunger and Brain Health

Lerodalcibep: Monthly PCSK9 Inhibitor to Lower LDL

What Oncology Pharmacists Value Most About the COA Conference

Lumateperone: One Capsule, Three Psychiatric Indications

New Trump EO Bolsters Psychedelics Space